our I Chris. Thanks, second pleased am financial with quarter results.
the million quarter in compared XXXX. to a of million income second on $XX increase we a net $XXX per For revenue diluted XXXX, basis, GAAP of $X.XX XX% revenue, share delivered and of or
in included direct of have associated As our with chosen costs majority COVID-XX. a we reminder, service. apply these only funds Act are to The of to cost costs CARES
income results Slide temporary onetime income adjusting impacted we in adjustment supplemental our items items of statement characterized XX have or regarding line the the by expense these items detail that as our For non-core, results GAAP each slides provides nature. quarter, and our were or impacts.
that and associated note direct adjustments costs recognition of funds Act COVID-XX. include with You’ll CARES our the
Additionally, a million matter, include investment $XX during the reserve results quarter of a XXXX, $X.X well in as our reversal million quarter. our as GAAP on DOJ closed Medalogix for the for was which second gain
follows: EPS $XX second visits increased XX% on representing or were added $XX revenue as of $X.XX to recent sequestration utilization in to basis, XX% consolidated XXXX prior $XX home suspension basis revenue results points QX percentage improvement Significant results in as episode rate $XX a million. a and health an million. over to or per gross a items represents And $XX XXX revenue, EBITDA in per XX% health year. drove are $X.XX For increases reduction or the quarter episode, million the And as history. the home XX%, company million to gross improvement per million share. our in AseraCare which of and point contributed in a our million follows: adjusted $XXX EBITDA revenue revenue margin clinician increased increased our impacting EBITDA highest XXX and grew in acquisition basis margin. million margin. $XX Improvement increase to
compared same-store our total increase of the patients in adjusted driven of episode quarter up $XX home in X suspension prior per is segment year, second our timing per is reimbursement, In to $XXX revenue dispersion The additional the in to an allocation. or increase million, up turning million a result Revenue segment EBITDA the X%. missed $XXX of was a of change or decline keep functional year, in of of prior in performance, Now level and in health, pre-corporate XX%. XX% from mind, growth LUPAs increase in to was a episode revenue by related COVID-XX our and impairment sequestration, X.X% resulting geographic patients. month visits admissions a
episode, by visit on our prior X.X over scores. we cost clinician to while per Visiting in contract Medalogix and driven led increased planned of continue The driven in year. an implementation X% new higher wage pay, a was quality per a visits rates increase the and of utilization costs. significant Care reduction growth increase by increase Our hire has of improving clinicians COVID-XX in and insurance increases
per business in with million, staff on X% QX a G&A X% episode, PDGM. improvement. driven revenue driven Our The $XX was utilization admissions higher related administrative staffing EBITDA which lower spend episode. XXX basis significantly COVID-XX and gross raises, higher representing $X.X in our increase clinical increased model, XXXX $XX a up benefited visit. to XX.X%, of a significant development variable points increases in of driven EBITDA cost and was million our increase approximately related despite Segment costs, and increase $XX EBITDA million, by per point improved and in million, improvement per revenue insurance the from business health the $XX was investments up resources by XXX volumes. and by segment Sequentially, nature care margin mix mainly in to progress center margin basis an strong
closed segment AseraCare quarter, an over for was the million, $XX increase our year, $XXX includes Now addition which of results, acquisition, which turning hospice X.X% million by X% of June of up on second prior the XXXX. up a XXXX. was additional per that suspension X%, hospice to day the rate revenue a into driven revenue went month Net X, and an sequestration increase X, October effect,
AseraCare was increase of EBITDA COVID due due million million, employees to to lingering the million, increased G&A and the raises, acquisition and and of decrease transportation development As of decreased in training. additions largely increased impacted a $X declined our revenue health AseraCare discussed, restrictions by added ADC the XX%. and admissions primarily primarily this hospice as travel revenue year $X.XX, was EBITDA incremental driven development costs, $X increase turnover by approximately all The training. an X% $XX insurance million costs. and $XX segment in higher segment’s performed business of staff to business and million, and travel down prior quarter. performance EBITDA impacts million, per an and $X Hospice Sequentially, as by costs, insurance grew impacted Chris COVID adjustments, $X.X higher cost growth. to business acquisition due health day X% access
offset by acquisition. spend accruals. higher The and insurance prior to to a year-over-year total $XXX investments support slowdown incentive additional PDGM, resources total decrease expenses, our an million development AseraCare of the and general to in an is health to which related due Turning million basis, and adjusted business costs costs, additional or operational raises, COVID-XX, total million in increase administrative $X.X includes increase in reflects on XX.X% of year’s related G&A revenue, was a $XX and
cash strong producing in impressive from million internal DSO the X.X second and was cash due down operations. in Cash to collections. quarter generate X.X was increased days operations continue cash We Year-over-year, ahead of our $XX flow from flow flow projections sequentially. days to
result continued quarter strong a the was flow, of our of X.Xx. at leverage our end ratio As cash the net
assets the well. activity Turning to M&A, with started in in acquired a on We Carolina. regulatory of an QX off North health as May we increase M&A X, home County, provider Randolph
we of a In on XX. July on X, Contessa addition New closed with hospice Westchester provider Association, on Visiting on County, locations and August X. of acquisition Nurse to the Nebraska Iowa, in acquired in we home And health and York, closing a CON July
$X new Board by also that the closed extension will the growth. Under our additional announced of which which million our approved secured execution impacts we for stock our closing the credit facility. hospice extension. the the Directors additional continued for have authorization connection and seamless the of amendment our senior remaining In also an health We you of a used adds million opportunistically, business banking Thank we this Neither facility, or nor million home stock billion core to repurchase authorization $XXX Bank for to partners term has the acquisition, the and on to million deal Contessa $XX ability be led revolver, $XXX on repurchases, will previous credit with which authorization. have $XXX Contessa assets. loan organic and will a our from of deploy we acquire America
for impact of This we’re reflects Finally, our updating the updated our slide lingering hospice on and business. can ranges as its of the resurgence on supplemental guidance guidance XXXX. COVID effect XX deck, our you of see Page
Our are: $X.XX of these of the of $XXX are: to EPS $X.XX to Contessa $X.XX core $XXX of million, Including to of adjusted the billion adjusted $XXX to and impact primarily $X.XX billion, $X.XX. billion adjusted million, to acquisitions, of million ranges $XXX EBITDA adjusted $X.XX ranges to adjusted EBITDA business EPS billion, $X.XX of revenue revenue adjusted the $X.XX. million VNA, and guidance
and in Our performance half produced were our our was XXXX and of first projections, in the growth confident outlook. expanded margins, hospice strong EBITDA behind we though
we XXXX growing facilities are into the ADC guidance second to hospice after and ranges mindful of our states, prudent utilization we around Throughout adjust in difficulties primarily need down. our surges deliver have need continued key admit react, line half feel reduction in health been our how for BD and reduction results XXXX costs. growth, referral the QX to aggressively we our Given and the sources have guidance pressures. staff managed XXXX, and of COVID-XX, contractors The and facing recent costs drivers and in higher top uncertainty in of it
significant with has to recent our and impact both However, near-term Amedisys to this hiring isolated believe we grow and still hire hospice is staffing hospice issue, future acquisition continue growth given typically committed a been in us used segment which not invest the segment, operating cost support Accordingly, COVID-XX has to and a our activity, systematic clinical opportunity in to growth. despite metrics that and to disruption we’re core leadership is both forecast required for employees hospice has that our growth assumptions in impacted turnover and to margins. this our growth for opportunity the there Contessa.
BD I’ll our operating to ability environment. clinicians further back our disease senior itself to staff basing interventions, guidance occupancy on this the and guidance. as our and economy. impact could Any and current to patient achieve are procedures, Paul? in COVID-XX the quarantine, healthcare over disruptions well elective living regulations now the as to government or evolve spiking decline future to systems in both in continues change conclude. the call in on reduction behavior Paul turn We